# Gerresheimer invests up to $94M in US glass vial production expansion

Gerresheimer AG will invest up to $94 million to expand its Morganton, North Carolina facility with new vial forming lines, increasing annual production capacity for Type 1 glass vials. The project is supported by BARDA with up to $66 million.

- Type: Expansion
- Announced: 2022-08-08
- Where: Morganton, North Carolina, United States
- Value: $94.0M
- Status: announced
- Products: glass vials, Type 1 borosilicate vials, aluminosilicate vials
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Gerresheimer](https://endata.com/companies/1928.md)
- [Biomedical Advanced Research and Development Authority](https://endata.com/companies/8807.md) (investor)

## Sources

- [gerresheimer.com](https://www.gerresheimer.com/en/customer/company/news/detail/gerresheimer-invests-up-to-94-million-dollar-in-us-production-facility), 2022-08-08: "Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced investments to rapidly expand its manufacturing, supply and logistics capability for glass vials in the U.S."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.